Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Aggregation and Adenosine Levels in CAD and CKD Patients on DAPT
NCT03039205Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in coronary artery disease (CAD), sponsored by Universidade de São Paulo. Started Nov 2017; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03039205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039205.